-
EP3080279
European procedure
Extract from the Register of European Patents
EP About this file: EP3080279
| EP3080279 - METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME [Right-click to bookmark this link] | Status | Patent revoked Status updated on 29.08.2023 Database last updated on 03.04.2025 | |
| Former | The patent has been granted Status updated on 24.08.2018 | ||
| Former | Grant of patent is intended Status updated on 02.05.2018 | ||
| Former | Examination is in progress Status updated on 07.04.2017 | Most recent event Tooltip | 19.07.2024 | Lapse of the patent in a contracting state | published on 21.08.2024 [2024/34] | Applicant(s) | For all designated states Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | [2016/42] | Inventor(s) | 01 /
FRENDEWEY, David c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | 02 /
AUERBACH, Wojtek c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | 03 /
LAI, Ka-Man Venus c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | 04 /
VALENZUELA, David M. c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | 05 /
YANCOPOULOS, George D. c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | [2017/01] |
| Former [2016/42] | 01 /
FRENDEWEY, David c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | ||
| 02 /
AUERBACH, Wojtek c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | |||
| 03 /
LAI, Ka-Man Venus c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | |||
| 04 /
KUNO, Junko c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | |||
| 05 /
VALENZUELA, David M. c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | |||
| 06 /
YANCOPOULOS, George D. c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | Representative(s) | Witthoff Jaekel Steinecke Patentanwälte PartG mbB Postfach 1140 52412 Jülich / DE | [N/P] |
| Former [2016/42] | Hutter, Anton, et al Venner Shipley LLP 200 Aldersgate London EC1A 4HD / GB | Application number, filing date | 14790457.7 | 15.10.2014 | [2016/42] | WO2014US60788 | Priority number, date | US201361914768P | 11.12.2013 Original published format: US 201361914768 P | US201462017416P | 26.06.2014 Original published format: US 201462017416 P | US201462029261P | 25.07.2014 Original published format: US 201462029261 P | US201462052906P | 19.09.2014 Original published format: US 201462052906 P | US201462059527P | 03.10.2014 Original published format: US 201462059527 P | [2016/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015088643 | Date: | 18.06.2015 | Language: | EN | [2015/24] | Type: | A1 Application with search report | No.: | EP3080279 | Date: | 19.10.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.06.2015 takes the place of the publication of the European patent application. | [2016/42] | Type: | B1 Patent specification | No.: | EP3080279 | Date: | 26.09.2018 | Language: | EN | [2018/39] | Search report(s) | International search report - published on: | EP | 18.06.2015 | Classification | IPC: | C12N15/85, C12N9/22 | [2016/42] | CPC: |
C12N15/907 (EP,US);
A01K67/0276 (EP);
A01K67/0278 (EP);
C12N15/1024 (EP,US);
C12N15/8509 (EP,US);
C12N9/22 (EP,US);
A01K2217/072 (EP);
A01K2217/075 (EP);
A01K2227/105 (EP);
A01K2267/0362 (EP);
A01K2267/0387 (EP);
C12N2800/40 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/42] | Extension states | BA | 29.06.2016 | ME | 29.06.2016 | Title | German: | VERFAHREN UND ZUSAMMENSETZUNGEN ZUR GEZIELTEN MODIFIKATION EINES GENOMS | [2016/42] | English: | METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME | [2016/42] | French: | PROCÉDÉS ET COMPOSITIONS POUR LA MODIFICATION CIBLÉE D'UN GÉNOME | [2016/42] | Entry into regional phase | 29.06.2016 | National basic fee paid | 29.06.2016 | Designation fee(s) paid | 29.06.2016 | Examination fee paid | Examination procedure | 29.06.2016 | Examination requested [2016/42] | 17.01.2017 | Amendment by applicant (claims and/or description) | 06.04.2017 | Despatch of a communication from the examining division (Time limit: M04) | 14.08.2017 | Reply to a communication from the examining division | 22.09.2017 | Despatch of a communication from the examining division (Time limit: M04) | 02.02.2018 | Reply to a communication from the examining division | 03.05.2018 | Communication of intention to grant the patent | 13.08.2018 | Fee for grant paid | 13.08.2018 | Fee for publishing/printing paid | 13.08.2018 | Receipt of the translation of the claim(s) | Divisional application(s) | EP18188401.6 / EP3460063 | EP24157885.5 / EP4349980 | Opposition(s) | Opponent(s) | 01
01.10.2018
ADMISSIBLE CMS Cameron McKenna Nabarro Olswang LLP Cannon Place 78 Cannon Street London EC4N 6AF / GB Opponent's representative CMS Cameron McKenna Nabarro Olswang LLP, et al, et al Cannon Place 78 Cannon Street London EC4N 6AF / GB | [2018/45] | 10.07.2019 | Invitation to proprietor to file observations on the notice of opposition | 20.11.2019 | Reply of patent proprietor to notice(s) of opposition | 14.08.2020 | Cancellation of oral proceeding that was planned for 26.11.2020 | 26.11.2020 | Date of oral proceedings | 26.04.2021 | Date of oral proceedings | 09.06.2021 | Despatch of interlocutory decision in opposition | 09.06.2021 | Despatch of minutes of oral proceedings | 03.08.2023 | Legal effect of revocation of patent [2023/40] | 17.08.2023 | Despatch of communication that the patent will be revoked | Appeal following opposition | 09.08.2021 | Appeal received No. T1294/21 | 09.08.2021 | Payment of appeal fee | 19.10.2021 | Statement of grounds filed | 03.08.2023 | Result of appeal procedure: revocation of the patent | 17.08.2023 | Despatch of the decision of the Board of Appeal | 11.08.2021 | Appeal received No. T1294/21 | 11.08.2021 | Payment of appeal fee | 18.10.2021 | Statement of grounds filed | 03.08.2023 | Result of appeal procedure: revocation of the patent | 17.08.2023 | Despatch of the decision of the Board of Appeal | 03.08.2023 | Date of oral proceedings | Fees paid | Renewal fee | 25.10.2016 | Renewal fee patent year 03 | 23.10.2017 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | RS | 15.10.2014 | [2024/34] | Cited in | International search | [Y]WO2006044962 (REGENERON PHARMA [US], et al); | [Y]WO2007117410 (MEDAREX INC [US], et al); | [E]WO2014172489 (REGENERON PHARMA [US]); | by applicant | WO9905266 | WO0236789 | US2002081614 | WO02057308 | US2003021776 | US6586251 | US6596541 | WO03078619 | US2003232410 | WO2004031346 | US2004177390 | US2005026157 | US2005064474 | US2005144655 | US2005208489 | WO2005105989 | US2006063231 | US2006188987 | US7105348 | WO2006097854 | WO2006097853 | WO2006097784 | US2006246567 | US7205148 | US7294754 | WO2008017234 | US2008078000 | US2008092249 | US2008182332 | US7576259 | US7612250 | US7659442 | WO2010079430 | US2010291048 | WO2011017293 | US2011104799 | US2011145940 | US2011239315 | US2011269234 | US2013123484 | US2013137101 | WO2013142578 | US2013312129 | WO2013176772 | US8697851 | WO2014065596 | WO2014089290 | WO2014093622 | WO2014099750 | WO2014131833 | WO2001US45375 | Opposition | GB1316560 | WO2015040402 | WO2015188109 |